Molecular LogiX


Public list: Pharma Startups (4732) Cancer Therapeutics (1137)

Molecular LogiX (MLX) is a drug discovery company located in The Woodlands, Texas, that seeks to discover therapeutics through the application of rationale protein engineering technologies. The company is currently developing protein-based drugs to treat cancer by interfering with established tumor growth factor pathways.

Molecular LogiX (MLX) is a drug discovery company located in The Woodlands, Texas, that seeks to discover therapeutics through the application of rationale protein engineering technologies. The company is currently developing protein-based drugs to t...Show all

Company (Alive / Active)

Phone: 281-298-9280

Fax:

4200 Research Forest Drive
Spring, 77381
Texas, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Molecular LogiX $0M Nov 30, 2018
See all 20 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Molecular LogiX Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 2 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

Five Prime Therapeutics

South San Francisco, California, United States
IPO / Went publicFive Prime Therapeutics is a clinical-stage biotechnology company with a pipeline of antibodies and ligand traps for cancer, autoimmunity and respiratory diseases. FivePrime has differentiated discovery capabilities built on its library of secreted and extracellular human proteins, which it leverages in cell-based assays, in vivo models and receptor-ligand matching screens to identify medically relevant new targets and therapeutic proteins. FivePrime has entered into a collaboration agreement to...Show allLogin to see details

Archemix

San Francisco, California, United States
Alive / ActiveArchemix discovers, develops, and commercializes therapeutic aptamers for the prevention and treatment of chronic and acute diseases. The Company's aptamer product candidates include ARC1779 for thrombotic microangiopathyies and carotid endarterectomy surgical procedure. The company also offers product candidates for cardiovascular, hematology, and oncology diseases.Login to see details
See all 20 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Pan-her antagonists and methods of use Jun 30, 2005 Jul 07, 2009 Patent